{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:16:28Z","timestamp":1774084588262,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,9,5]],"date-time":"2010-09-05T00:00:00Z","timestamp":1283644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11060-010-0383-6","type":"journal-article","created":{"date-parts":[[2010,9,5]],"date-time":"2010-09-05T09:09:20Z","timestamp":1283677760000},"page":"231-238","source":"Crossref","is-referenced-by-count":114,"title":["The detection of CMV pp65 and IE1 in glioblastoma multiforme"],"prefix":"10.1007","volume":"103","author":[{"given":"Kenneth G.","family":"Lucas","sequence":"first","affiliation":[]},{"given":"Lei","family":"Bao","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Bruggeman","sequence":"additional","affiliation":[]},{"given":"Kimberly","family":"Dunham","sequence":"additional","affiliation":[]},{"given":"Charles","family":"Specht","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,9,5]]},"reference":[{"issue":"3","key":"383_CR1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/neuonc\/3.3.152","volume":"3","author":"FG Davis","year":"2001","unstructured":"Davis FG et al (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 3(3):152\u2013158","journal-title":"Neuro Oncol"},{"issue":"2","key":"383_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1006091608586","volume":"40","author":"TS Surawicz","year":"1998","unstructured":"Surawicz TS et al (1998) Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40(2):151\u2013160","journal-title":"J Neurooncol"},{"issue":"2 Pt 1","key":"383_CR3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1158\/1078-0432.CCR-06-1576","volume":"13","author":"JG Zhang","year":"2007","unstructured":"Zhang JG et al (2007) Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics. Clin Cancer Res 13(2 Pt 1):566\u2013575","journal-title":"Clin Cancer Res"},{"issue":"2","key":"383_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11060-006-9220-3","volume":"81","author":"S Saikali","year":"2007","unstructured":"Saikali S et al (2007) Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy. J Neurooncol 81(2):139\u2013148","journal-title":"J Neurooncol"},{"issue":"19","key":"383_CR5","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1073\/pnas.93.19.10399","volume":"93","author":"JH Sampson","year":"1996","unstructured":"Sampson JH et al (1996) Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the \u201cimmunologically privileged\u201d central nervous system. Proc Natl Acad Sci USA 93(19):10399\u201310404","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"383_CR6","first-page":"842","volume":"61","author":"JS Yu","year":"2001","unstructured":"Yu JS et al (2001) Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61(3):842\u2013847","journal-title":"Cancer Res"},{"key":"383_CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-065X.2008.00603.x","volume":"222","author":"DA Mitchell","year":"2008","unstructured":"Mitchell DA, Fecci PE, Sampson JH (2008) Immunotherapy of malignant brain tumors. Immunol Rev 222:70\u2013100","journal-title":"Immunol Rev"},{"issue":"15","key":"383_CR8","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1158\/1078-0432.CCR-05-0464","volume":"11","author":"LM Liau","year":"2005","unstructured":"Liau LM et al (2005) Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res 11(15):5515\u20135525","journal-title":"Clin Cancer Res"},{"issue":"6","key":"383_CR9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1227\/00006123-198812000-00007","volume":"23","author":"RE Merchant","year":"1988","unstructured":"Merchant RE et al (1988) Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor. Neurosurgery 23(6):725\u2013732","journal-title":"Neurosurgery"},{"issue":"1","key":"383_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1227\/00006123-199101000-00003","volume":"28","author":"KO Lillehei","year":"1991","unstructured":"Lillehei KO et al (1991) Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy. Neurosurgery 28(1):16\u201323","journal-title":"Neurosurgery"},{"issue":"5","key":"383_CR11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00002371-200409000-00009","volume":"27","author":"RO Dillman","year":"2004","unstructured":"Dillman RO et al (2004) Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma. J Immunother 27(5):398\u2013404","journal-title":"J Immunother"},{"issue":"1\u20132","key":"383_CR12","first-page":"63","volume":"19","author":"D Serraino","year":"2005","unstructured":"Serraino D et al (2005) Infection with Epstein-Barr virus and cancer: an epidemiological review. J Biol Regul Homeost Agents 19(1\u20132):63\u201370","journal-title":"J Biol Regul Homeost Agents"},{"issue":"2","key":"383_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/088282403322017866","volume":"16","author":"GL Eiben","year":"2003","unstructured":"Eiben GL et al (2003) Cervical cancer vaccines: recent advances in HPV research. Viral Immunol 16(2):111\u2013121","journal-title":"Viral Immunol"},{"issue":"2","key":"383_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2004.12.009","volume":"9","author":"FX Bosch","year":"2005","unstructured":"Bosch FX et al (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9(2):191\u2013211, v","journal-title":"Clin Liver Dis"},{"issue":"5","key":"383_CR15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11912-003-0021-y","volume":"5","author":"RA Vilchez","year":"2003","unstructured":"Vilchez RA, Butel JS (2003) Simian virus 40 and its association with human lymphomas. Curr Oncol Rep 5(5):372\u2013379","journal-title":"Curr Oncol Rep"},{"issue":"9345","key":"383_CR16","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(02)11524-8","volume":"360","author":"L Harkins","year":"2002","unstructured":"Harkins L et al (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360(9345):1557\u20131563","journal-title":"Lancet"},{"issue":"12","key":"383_CR17","first-page":"3347","volume":"62","author":"CS Cobbs","year":"2002","unstructured":"Cobbs CS et al (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62(12):3347\u20133350","journal-title":"Cancer Res"},{"issue":"3","key":"383_CR18","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","volume":"170","author":"M Samanta","year":"2003","unstructured":"Samanta M et al (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170(3):998\u20131002","journal-title":"J Urol"},{"issue":"1","key":"383_CR19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1215\/15228517-2007-035","volume":"10","author":"DA Mitchell","year":"2008","unstructured":"Mitchell DA et al (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 10(1):10\u201318","journal-title":"Neuro Oncol"},{"issue":"1","key":"383_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00401-008-0359-1","volume":"116","author":"ME Scheurer","year":"2008","unstructured":"Scheurer ME et al (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116(1):79\u201386","journal-title":"Acta Neuropathol"},{"issue":"2","key":"383_CR21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/13550280600654573","volume":"12","author":"S Poltermann","year":"2006","unstructured":"Poltermann S et al (2006) Lack of association of herpesviruses with brain tumors. J Neurovirol 12(2):90\u201399","journal-title":"J Neurovirol"},{"issue":"6","key":"383_CR22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/modpathol.3800352","volume":"18","author":"SK Lau","year":"2005","unstructured":"Lau SK et al (2005) Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18(6):838\u2013843","journal-title":"Mod Pathol"},{"key":"383_CR23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.femsre.2003.07.005","volume":"28","author":"J Cinatl","year":"2008","unstructured":"Cinatl J et al (2008) Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for a viral infection in tumor progression. FEMS Microbiol Rev 28:59\u201377","journal-title":"FEMS Microbiol Rev"},{"issue":"12","key":"383_CR24","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/j.1460-2075.1994.tb06584.x","volume":"13","author":"C Hagemeier","year":"1994","unstructured":"Hagemeier C et al (1994) Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J 13(12):2897\u20132903","journal-title":"EMBO J"},{"issue":"11","key":"383_CR25","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1128\/JVI.71.11.8176-8185.1997","volume":"71","author":"EA Fortunato","year":"1997","unstructured":"Fortunato EA et al (1997) Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J Virol 71(11):8176\u20138185","journal-title":"J Virol"},{"issue":"7","key":"383_CR26","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1074\/jbc.271.7.3534","volume":"271","author":"HL Tsai","year":"1996","unstructured":"Tsai HL et al (1996) Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J Biol Chem 271(7):3534\u20133540","journal-title":"J Biol Chem"},{"issue":"10","key":"383_CR27","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbmt.2008.07.014","volume":"14","author":"L Bao","year":"2008","unstructured":"Bao L et al (2008) Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 14(10):1156\u20131162","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"383_CR28","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.4049\/jimmunol.165.7.4105","volume":"165","author":"Q Sun","year":"2000","unstructured":"Sun Q et al (2000) B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen. J Immunol 165(7):4105\u20134111","journal-title":"J Immunol"},{"issue":"2","key":"383_CR29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3171\/jns.2004.100.2.0310","volume":"100","author":"I Yang","year":"2004","unstructured":"Yang I et al (2004) Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme. J Neurosurg 100(2):310\u2013319","journal-title":"J Neurosurg"},{"issue":"7","key":"383_CR30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/107999003322226032","volume":"23","author":"SB Read","year":"2003","unstructured":"Read SB et al (2003) Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification. J Interferon Cytokine Res 23(7):379\u2013393","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"383_CR31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.1452","volume":"94","author":"A Serrano","year":"2001","unstructured":"Serrano A et al (2001) Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2\u2032-deoxycytidine treatment. Int J Cancer 94(2):243\u2013251","journal-title":"Int J Cancer"},{"issue":"Pt 12","key":"383_CR32","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-67-12-2605","volume":"67","author":"T Ogura","year":"1986","unstructured":"Ogura T et al (1986) Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics. J Gen Virol 67(Pt 12):2605\u20132616","journal-title":"J Gen Virol"},{"issue":"19","key":"383_CR33","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1128\/JVI.00866-07","volume":"81","author":"MH Luo","year":"2007","unstructured":"Luo MH, Fortunato EA (2007) Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells. J Virol 81(19):10424\u201310436","journal-title":"J Virol"},{"issue":"4","key":"383_CR34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bjc.6602339","volume":"92","author":"J Sabatier","year":"2005","unstructured":"Sabatier J et al (2005) Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92(4):747\u2013750","journal-title":"Br J Cancer"},{"issue":"9","key":"383_CR35","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","volume":"43","author":"SA Staras","year":"2006","unstructured":"Staras SA et al (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988\u20131994. Clin Infect Dis 43(9):1143\u20131151","journal-title":"Clin Infect Dis"},{"issue":"2","key":"383_CR36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jca.20157","volume":"23","author":"CE Boeke","year":"2008","unstructured":"Boeke CE et al (2008) CMV antibody prevalence and seroincidence in plateletpheresis donors. J Clin Apher 23(2):63\u201365","journal-title":"J Clin Apher"},{"issue":"11","key":"383_CR37","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","volume":"190","author":"B Thurner","year":"1999","unstructured":"Thurner B et al (1999) Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190(11):1669\u20131678","journal-title":"J Exp Med"},{"key":"383_CR38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1600-065X.2002.18804.x","volume":"188","author":"PG Coulie","year":"2002","unstructured":"Coulie PG et al (2002) Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen. Immunol Rev 188:33\u201342","journal-title":"Immunol Rev"},{"issue":"1\u20132","key":"383_CR39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jim.2005.11.023","volume":"310","author":"WY Ho","year":"2006","unstructured":"Ho WY et al (2006) In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire. J Immunol Methods 310(1\u20132):40\u201352","journal-title":"J Immunol Methods"},{"issue":"3","key":"383_CR40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.168.3.919","volume":"168","author":"LK Borysiewicz","year":"1988","unstructured":"Borysiewicz LK et al (1988) Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med 168(3):919\u2013931","journal-title":"J Exp Med"},{"issue":"3","key":"383_CR41","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1128\/JVI.62.3.1066-1070.1988","volume":"62","author":"YN Liu","year":"1988","unstructured":"Liu YN, Kari B, Gehrz RC (1988) Human immune responses to major human cytomegalovirus glycoprotein complexes. J Virol 62(3):1066\u20131070","journal-title":"J Virol"},{"issue":"5361","key":"383_CR42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.280.5361.248","volume":"280","author":"HL Ploegh","year":"1998","unstructured":"Ploegh HL (1998) Viral strategies of immune evasion. Science 280(5361):248\u2013253","journal-title":"Science"},{"issue":"1C","key":"383_CR43","first-page":"605","volume":"20","author":"S Oshiro","year":"2000","unstructured":"Oshiro S et al (2000) Response of MHC class-1 antigen on rat glioma cells to cytokines. Anticancer Res 20(1C):605\u2013610","journal-title":"Anticancer Res"},{"issue":"2","key":"383_CR44","first-page":"223","volume":"76","author":"V Piguet","year":"1986","unstructured":"Piguet V et al (1986) Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones. J Natl Cancer Inst 76(2):223\u2013228","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"383_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-5728(92)90030-O","volume":"36","author":"PY Wen","year":"1992","unstructured":"Wen PY, Lampson MA, Lampson LA (1992) Effects of gamma-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy. J Neuroimmunol 36(1):57\u201368","journal-title":"J Neuroimmunol"},{"key":"383_CR46","doi-asserted-by":"crossref","unstructured":"Mitchell D et al (2008) Efficacy of a phase II vaccine targeting cytomegalovirus antigens in newly-diagnosed GBM. J Clin Oncol 26:2042","DOI":"10.1200\/jco.2008.26.15_suppl.2042"},{"issue":"5","key":"383_CR47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMc0804818","volume":"359","author":"RM Prins","year":"2008","unstructured":"Prins RM, Cloughesy TF, Liau LM (2008) Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 359(5):539\u2013541","journal-title":"N Engl J Med"},{"issue":"5","key":"383_CR48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/CJI.0b013e31803b945b","volume":"30","author":"L Bao","year":"2007","unstructured":"Bao L, Sun Q, Lucas KG (2007) Rapid generation of CMV pp65-specific T cells for immunotherapy. J Immunother (1997) 30(5):557\u2013561","journal-title":"J Immunother (1997)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0383-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0383-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T07:58:42Z","timestamp":1591862322000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0383-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0383-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,5]]}}}